Articaine — 5 Marks (Anaesthesia Exam Answer)

1. Introduction

2. Chemistry

• Amide-type local anesthetic, but instead of the usual benzene ring, it has a thiophene ring — this increases lipophilicity and improves tissue penetration.
• Contains an extra ester group in its side chain, which is hydrolyzed by plasma (nonspecific) cholinesterases.
• Marketed as a 4% solution (uniquely high concentration compared to other dental anesthetics, e.g. lidocaine max 2%).

3. Pharmacokinetics

4. Mechanism of Action

5. Clinical Uses

• Primarily dental and periodontal local/infiltration anesthesia and inferior alveolar nerve block (most common use).
• Investigated for intrathecal/spinal anesthesia: doses of 50-80 mg (with or without glucose) give rapid-onset spinal block lasting about 1 hour, with faster recovery than bupivacaine.
• Compared with epidural lidocaine (2% articaine), shows similar latency, spread, duration, and motor block; also used in obstetric epidural analgesia.

6. Advantages

• Rapid onset, good tissue penetration (better diffusion through bone, useful in dentistry).
• Short plasma half-life -> theoretically better safety margin for systemic toxicity.
• Generally considered as effective, and possibly safer, than lidocaine in dental blocks.
• Faster recovery profile than bupivacaine when used intrathecally.

7. Adverse Effects / Toxicity

• Paresthesia risk: persistent paresthesia is rare but reported to be about 3 times more common with articaine than other agents (though prilocaine's risk is even higher, about twice that of articaine).
• This enhanced neurotoxic risk is thought to be related to the 4% concentration used (concentration-dependent neurotoxicity) rather than an intrinsic property of the drug itself — many US/Canadian dental schools have now stopped using 4% articaine for mandibular nerve blocks for this reason.
• General local anesthetic systemic toxicity (LAST) applies if inadvertent intravascular injection occurs: CNS excitation progressing to seizures, cardiovascular depression/arrhythmias.

8. Contraindications / Precautions

• Caution in mandibular nerve blocks due to paresthesia risk with the 4% formulation.
• Standard local anesthetic precautions: known hypersensitivity, caution in patients with pseudocholinesterase deficiency (delayed metabolism), and standard cardiovascular precautions with vasoconstrictor-containing preparations (usually combined with epinephrine 1:100,000 or 1:200,000).

Summary Table

Dose of Articaine

Maximum Recommended Dose (MRD)

Cartridge Calculation

• Standard dental cartridge = 1.8 mL → 4% articaine cartridge = 40 mg/mL × 1.8 mL = 72 mg per cartridge
• Quick clinical rule of thumb: ~1 cartridge per 10 kg body weight (approximate, always calculate formally for children/low-weight patients)
• Example: 70 kg adult → max dose = 7 mg/kg × 70 kg = 490 mg ≈ 6-7 cartridges

Onset and Duration (dental infiltration/block)

• Onset: 1-6 minutes
• Duration of soft tissue/pulpal anesthesia: approximately 1 hour (pulpal ~45-60 min, soft tissue longer with epinephrine)

Intrathecal/Spinal Use (less common, mainly research/off-label in some countries)

• Dose range: 50-80 mg, with or without glucose (hyperbaric preparation), producing rapid-onset spinal block lasting about 1 hour with faster recovery than bupivacaine.

Practical Notes for the Exam

• Because articaine is the only dental anesthetic marketed at 4% (others are ≤2%), and neurotoxicity risk is partly concentration-dependent, many clinicians now avoid 4% articaine for inferior alveolar nerve block specifically, using buccal infiltration techniques instead where feasible.
• Always reduce dose in pediatric, elderly, and hepatic/cardiac impaired patients, and factor in the epinephrine dose ceiling (especially in cardiac patients) alongside the articaine mg/kg limit.